Rxivist logo

A CRISPRi/a platform in iPSC-derived microglia uncovers regulators of disease states

By Nina M Draeger, Sydney M Sattler, Cindy Tzu-Ling Huang, Olivia M Teter, Kun Leng, Sayed Hadi Hashemi, Jason Hong, Claire D Clelland, Lihong Zhan, Lay Kodama, Andrew B. Singleton, Mike A Nalls, Justin Ichida, Michael E Ward, Faraz Faghri, Li Gan, Martin Kampmann

Posted 16 Jun 2021
bioRxiv DOI: 10.1101/2021.06.16.448639

Microglia are emerging as key drivers of neurological diseases. However, we lack a systematic understanding of the underlying mechanisms. Here, we present a screening platform to systematically elucidate functional consequences of genetic perturbations in human iPSC-derived microglia. We developed an efficient eight-day protocol for the generation of microglia-like cells based on the inducible expression of six transcription factors. We established inducible CRISPR interference and activation in this system and conducted three screens targeting the "druggable genome". These screens uncovered genes controlling microglia survival, activation and phagocytosis, including neurodegeneration-associated genes. A screen with single-cell RNA sequencing as the readout revealed that these microglia adopt a spectrum of states mirroring those observed in human brains and identified regulators of these states. A disease-associated state characterized by SPP1 expression was selectively depleted by CSF1R inhibition. Thus, our platform can systematically uncover regulators of microglia states, enabling their functional characterization and therapeutic targeting.

Download data

  • Downloaded 2,012 times
  • Download rankings, all-time:
    • Site-wide: 9,277
    • In neuroscience: 910
  • Year to date:
    • Site-wide: 1,628
  • Since beginning of last month:
    • Site-wide: 647

Altmetric data

Downloads over time

Distribution of downloads per paper, site-wide